- Home
- Life Sciences
- Pharmaceutical
- Drug and Medication
- Drug and Medication Analysis & Statistics in Japan, May 2013
Talk to Alison
00 1 718 618 48 97
Search inside this page
Publication dates
Publishers
- Global Markets Direct (40)
- Global Data (39)
- GBI Research (8)
- Business Monitor International (88)
- Global Research & Data Services (9)
-
- ICD Research (5)
- Datamonitor (24)
- Espicom Business Intelligence (18)
- VacZine Analytics Group Of Assay Advantage Ltd (14)
- Euromonitor International (8)
- SCRIP Insights (5)
- Global Industry Analyst (4)
- Business Review (2)
- Canadean Ltd (2)
- Frost & Sullivan (2)
- Infiniti Research Limited (2)
- Koncept Analytics (2)
- La Merie Publishing (2)
- Pacific Bridge Medical (2)
- Visiongain (2)
- World Market Intelligence Ltd (2)
- Barnes Reports (1)
- Daedal Research (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- Greystone Research Associates (1)
- Ken Research Private (1)
- Leatherhead Food Research (1)
- MarketLine (1)
- Urch Publishing (1)
data types
Free Market Research Guides to Download
Drug and Medication Analysis & Statistics in Japan, May 2013
You might be interested in: drug, vaccine, insulin, more »
» Purchase Premium Reports
1-40 of about 200 reports
PharmaPoint: Osteoporosis - Japan Drug Forecast and Market Analysis to 2022
- $ 4 995
- Industry report
- February 2013
- by Global Data
PharmaPoint: Osteoporosis - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Osteoporosis - Japan Drug Forecast and Market Analysis ...
- Industries : Drug and Medication
- Countries : Japan
Vaccines - Top 10 Global Markets Package
- $ 5 174
- Industry report
- May 2013
- by Global Research & Data Services
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...
- Industries : Drug and Medication
- Countries : World, United States, United Kingdom, Russian Federation, Italy, France, Germany, Japan, India, China, Europe
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants
- $ 3 500
- Industry report
- April 2013
- by GBI Research
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants ...
- Industries : Drug and Medication
- Countries : Philippines, Singapore, New Zealand, Australia, Malaysia, Taiwan, Japan, China, Asia, India, Oceania, World
Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth
- $ 3 500
- Industry report
- April 2013
- by GBI Research
Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth Summary The leading business intelligence provide ...
- Industries : Drug and Medication
- Countries : Japan, United States, Europe, World
Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth
- $ 3 500
- Industry report
- May 2013
- by GBI Research
Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth Summary The leading business intelligence provider GBI Research has released its ...
- Industries : Drug and Medication
- Countries : Japan
World Pathology: Pertussis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Pertussis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Drug and Medication
- Countries : Japan, World
Encephalitis - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Encephalitis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Encephalitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Drug and Medication
- Countries : Japan, World, Venezuela, United States, China
World Drug and Medication: Tetanus - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Tetanus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
- Industries : Drug and Medication
- Countries : Japan, World, United States, Australia
Anesthetic Effect - Pipeline Review, H1 2013
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
Anesthetic Effect - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Anesthetic Effect - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...
- Industries : Drug and Medication
- Countries : Japan, World
World Drug Discovery and Development: Acromegaly - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Acromegaly, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Drug and Medication
- Countries : Japan, World, United States
Pathology in United States: Diphtheria - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Diphtheria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Drug and Medication
- Countries : Japan, World, United States, Australia
World Pathology: Hyperlipidemia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Hyperlipidemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Drug and Medication
- Countries : Japan, World
Japan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012
- $ 1 088
- Industry report
- February 2013
- by Business Monitor International
BMI View: Japan's pharmaceutical industry is highly attractive to both foreign and local drugmakers. All three sub-sectors - patented, generic and over-the-counter (OTC) medicines - are large and projection ...
- Industries : Drug and Medication
- Countries : Japan
Japan Pharmaceuticals and Healthcare Industry Update Quarter 3 2012
- $ 1 088
- Industry report
- May 2013
- by Business Monitor International
Includes 3 FREE quarterly updates BMI View: The prospects for Japan's pharmaceutical industry over the medium term are very positive. The country has one of the largest pensionable populations, healthcare ...
- Industries : Drug and Medication
- Countries : Japan
Vaccine Market in Japan
- $ 652
- Industry report
- May 2013
- by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Japan. The study provides essential market information for decision-makers including: ...
- Industries : Drug and Medication
- Countries : Japan
ASKA Pharmaceutical Co., Ltd. (4514) - Financial and Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary ASKA Pharmaceutical Co., Ltd. (ASKA) is a pharmaceutical company, based in Japan. It manufactures sells, imports and exports pharmaceuticals, veterinary medicines, quasi-drugs, foods, and medical ...
- Industries : Drug and Medication
- Countries : Japan
Toyama Chemical Co., Ltd. - Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary Toyama Chemical Co., Ltd.(Toyama Chemical) engages in the research, development, manufacture, and sale of pharmaceuticals in Japan and internationally. The company works on three fields,namely, ...
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Eurbn, 5 Year Trailing Cagr, %
- $ 250
- Industry data
- January 2013
Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Us$bn, 10 Year Forward Cagr, %
- $ 250
- Industry data
- January 2013
Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Eurbn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2021
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Eurbn, 5 Year Forward Cagr, %
- $ 250
- Industry data
- January 2013
Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Eurbn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2021
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Eurbn, 10 Year Forward Cagr, %
- $ 250
- Industry data
- January 2013
Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Us$bn, 5 Year Forward Cagr, %
- $ 250
- Industry data
- January 2013
Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Eisai Co., Ltd. (4523) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- March 2013
- by Global Data
Summary Eisai Co., Ltd. (Eisai) is a human healthcare company. It focuses on the research, development, manufacture and commercialization of prescription pharmaceuticals and consumer health products, generic ...
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Us$bn, 5 Year Trailing Cagr, %
- $ 250
- Industry data
- January 2013
Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2021
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Japan Patented Drug Sales, Us$bn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2021
By Business Monitor International
Source: Pharmaceuticals and Medical Devices Agency (PDMA), local companies, BMI
- Industries : Drug and Medication
- Countries : Japan
Eisai Co., Ltd. : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report
- $ 125
- Company report
- April 2013
- by ICD Research
Synopsis ICD Research's "Eisai Co., Ltd. : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. The ...
- Industries : Drug and Medication
- Countries : Japan
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022
- $ 4 995
- Industry report
- February 2013
- by Global Data
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022?. ...
- Industries : Drug and Medication
- Countries : Japan
PharmaPoint: HIV - Japan Drug Forecast and Market Analysis to 2022
- $ 4 995
- Industry report
- January 2013
- by Global Data
PharmaPoint: HIV - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: HIV - Japan Drug Forecast and Market Analysis to 2022?. Human ...
- Industries : Drug and Medication
- Countries : Japan
The Pharmaceutical Market: Japan, Business Monitor International
- $ 1 266
- Industry report
- January 2013
- by Business Monitor International
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN JAPAN Japan's ageing and affluent population represents strong opportunities for foreign ...
- Industries : Drug and Medication
- Countries : Japan
Elvitegravir (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Elvitegravir (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Elvitegravir (HIV) - Forecast and Market Analysis to 2022?. Human ...
- Industries : Drug and Medication
- Countries : Japan, Brazil, China, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Toyama Chemical Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- January 2013
- by Global Data
Summary Toyama Chemical Co., Ltd.(Toyama Chemical) engages in the research, development, manufacture, and sale of pharmaceuticals in Japan and internationally. The company works on three fields,namely, ...
- Industries : Drug and Medication
- Countries : Japan
Pfizer Japan Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- January 2013
- by Global Data
Summary Pfizer Japan Inc. (Pfizer Japan) is a pharmaceutical company, based in Japan. The company discovers, develops and commercializes prescribed medicines for humans and animals under consumer healthcare ...
- Industries : Drug and Medication
- Countries : Japan
DNAVEC Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- January 2013
- by Global Data
Summary DNAVEC Corporation (DNAVEC) is a biotechnology company, based in Japan. It develops technologies such as, sendai virus vector and simian immunodeficiency virus vector. The company's products include ...
- Industries : Drug and Medication
- Countries : Japan, China
Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share
- $ 3 500
- Industry report
- January 2013
- by GBI Research
Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share Summary GBI Research, the leading business intelligence provider, has ...
- Industries : Drug and Medication
- Countries : Japan, World, Europe, United States
Parkinson%s Disease: World Drug Market 2013-2023
- $ 2 492
- Industry report
- January 2013
- by Visiongain
Report Details Your guide to sales outlooks and R&D for treating Parkinson's Where are treatments for Parkinson's disease heading - technological and commercial outlooks? Visiongain's updated report gives ...
- Industries : Drug and Medication
- Countries : World, United States, Japan, Spain, Italy, France, Germany, United Kingdom, Europe
PharmaPoint: Prostate Cancer - Japan Drug Forecast and Market Analysis to 2022
- $ 4 995
- Industry report
- December 2012
- by Global Data
PharmaPoint: Prostate Cancer - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Prostate Cancer - Japan Drug Forecast and Market Analysis ...
- Industries : Drug and Medication
- Countries : Japan
Therapy in Japan: Japanese Encephalitis - Pipeline Review, H2 2011
- $ 2 000
- Company report
- December 2012
- by Global Markets Direct
Bacterial Conjunctivitis - Pipeline Review, H2 2011 Global Industries Direct's, 'Bacterial Conjunctivitis - Pipeline Review, H2 2011', provides an overview of the Bacterial Conjunctivitis therapeutic pipeline. ...
- Industries : Drug and Medication
- Countries : Japan
» Download Public Reports
About 200 reports
Company Report: Drug and Medication in The United Kingdom and Japan for Year 2012
- Company report
- September 2012
- 50 pages
- by Corporation
... Products, and we are currently evaluating around 50 investigational medicines for diseases such as cancer, diabetes, heart disease and respiratory illnesses. Over the next three years, we have ...
Company Report: Drug And Medication In Japan For Year 2012
September 2012Sbi Holdings Inc. - Company Report For Year 2012
November 2012Intercell Ag - Investment Analysis, December 2012
December 2012Robert Lee - Company Report For Year 2012
November 2012Drug And Medication Market In Japan
September 2012» Read our Company Profiles
5 CompaniesGlaxoSmithKline P.L.C.
United StatesJohnson and Johnson
United StatesNovartis Inc.
SwitzerlandSanofi-Aventis Senegal
SenegalGlaxoSmithKline PLC
United KingdomReportlinker.com © Copyright 2013. All rights reserved.
